Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) had its price target boosted by research analysts at UBS Group from $71.00 to $74.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's target price would suggest a potential upside of 12.50% from the company's current price.
A number of other research firms also recently commented on VMRK. Mizuho raised shares of Vivmark Residential Common Shares of Beneficial Interest from a "neutral" rating to an "outperform" rating and lifted their price objective for the stock from $70.00 to $73.00 in a report on Tuesday, September 8th. Barclays cut their price target on Vivmark Residential Common Shares of Beneficial Interest from $75.00 to $74.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 14th. BTIG Research reissued a "neutral" rating on shares of Vivmark Residential Common Shares of Beneficial Interest in a research note on Thursday, September 17th. Cantor Fitzgerald lowered their price objective on shares of Vivmark Residential Common Shares of Beneficial Interest from $70.00 to $68.00 and set a "neutral" rating on the stock in a research note on Monday. Finally, Royal Bank Of Canada cut their price objective on Vivmark Residential Common Shares of Beneficial Interest from $71.00 to $67.00 and set a "sector perform" rating for the company in a report on Tuesday, October 13th. Five research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Vivmark Residential Common Shares of Beneficial Interest currently has a consensus rating of "Hold" and a consensus price target of $71.42.
Read Our Latest Stock Analysis on VMRK
Vivmark Residential Common Shares of Beneficial Interest Stock Down 0.5%
Shares of Vivmark Residential Common Shares of Beneficial Interest stock traded down $0.36 during trading hours on Tuesday, hitting $65.78. The company's stock had a trading volume of 6,107,450 shares, compared to its average volume of 3,660,934. The firm has a fifty day moving average price of $62.61. Vivmark Residential Common Shares of Beneficial Interest has a 1-year low of $57.57 and a 1-year high of $71.50. The company has a quick ratio of 0.19, a current ratio of 0.19 and a debt-to-equity ratio of 0.77. The firm has a market cap of $24.66 billion, a P/E ratio of 243.63, a PEG ratio of 3.69 and a beta of 0.72.
Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $0.30 earnings per share for the quarter. The business had revenue of $785.05 million during the quarter. Vivmark Residential Common Shares of Beneficial Interest had a net margin of 27.97% and a return on equity of 8.06%. On average, sell-side analysts anticipate that Vivmark Residential Common Shares of Beneficial Interest will post 4.08 earnings per share for the current fiscal year.
Insider Buying and Selling at Vivmark Residential Common Shares of Beneficial Interest
In other Vivmark Residential Common Shares of Beneficial Interest news, Director Charles E. Mueller, Jr. sold 8,000 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $63.90, for a total transaction of $511,200.00. Following the transaction, the director directly owned 16,084 shares of the company's stock, valued at $1,027,767.60. This represents a 33.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Edward M. Schulman sold 16,595 shares of the company's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $64.29, for a total transaction of $1,066,892.55. Following the sale, the executive vice president directly owned 48,776 shares of the company's stock, valued at approximately $3,135,809.04. This represents a 25.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 58,286 shares of company stock valued at $3,735,822 in the last quarter. Corporate insiders own 1.20% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Blume Capital Management Inc. bought a new position in Vivmark Residential Common Shares of Beneficial Interest in the third quarter worth $25,000. Physician Wealth Advisors Inc. acquired a new position in shares of Vivmark Residential Common Shares of Beneficial Interest during the third quarter valued at $27,000. Farmers & Merchants Investments Inc. acquired a new stake in shares of Vivmark Residential Common Shares of Beneficial Interest during the 3rd quarter worth approximately $31,000. Planning Strategies Inc. lifted its holdings in Vivmark Residential Common Shares of Beneficial Interest by 87.5% in the third quarter. Planning Strategies Inc. now owns 538 shares of the company's stock valued at $33,000 after buying an additional 251 shares during the period. Finally, Mather Group LLC. bought a new position in shares of Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter worth $33,000. Institutional investors own 92.68% of the company's stock.
About Vivmark Residential Common Shares of Beneficial Interest
(
Get Free Report)
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vivmark Residential Common Shares of Beneficial Interest, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivmark Residential Common Shares of Beneficial Interest wasn't on the list.
While Vivmark Residential Common Shares of Beneficial Interest currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.